Moderna files for U.S. vaccine authorization, will seek EU nod
- Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
